Dorzolamide is a carbonic anhydrase inhibitor that reduces elevated intraocular pressure associated with glaucoma or ocular hypertension.
Dorzolamide belongs to a class of medications called carbonic anhydrase inhibitors. It works primarily in the eye to lower fluid pressure. You will find dorzolamide as the active ingredient in several eye-drop products, the most recognised being Cosopt.
In Hong Kong, the principal product that contains dorzolamide is Cosopt eye drops. Cosopt combines dorzolamide with the beta-blocker timolol maleate, offering a dual-action formula. It is supplied in sterile plastic bottles, typically in a 0.5 % dorzolamide concentration. Both the generic version and the branded bottle are available through pharmacies and hospitals that dispense prescription eye medicines. While other formulations exist in some markets, Cosopt is the main option approved for use in Hong Kong.
These conditions affect adults of varying ages, and dorzolamide is used as part of a broader treatment plan overseen by eye-care specialists.
When applied as an eye drop, dorzolamide blocks the enzyme carbonic anhydrase in the cells that produce aqueous humour, the fluid inside the eye. This blockage reduces the amount of fluid formed, leading to a gradual decline in eye pressure. The effect begins within a few hours after a drop is instilled and continues with regular use.
Most people notice only mild, temporary sensations after using dorzolamide-containing drops. Typical reports include a slight burning or stinging feeling, a temporary blurred vision, or a mild metallic taste in the mouth. These sensations usually subside as the eyes adjust to the medication.
Rarely, severe eye irritation, swelling, or vision changes may occur. Symptoms such as sudden eye pain, marked redness, or loss of vision require urgent medical attention. Likewise, systemic allergic responses-such as swelling of the lips, tongue, or throat, or difficulty breathing-must be treated as an emergency.
People with a known allergy to sulfonamide drugs should avoid dorzolamide. Individuals with severe lung disease, certain heart conditions, or a history of severe allergic reactions should discuss the suitability of dorzolamide-containing products with their eye-care provider before beginning treatment.
Dorzolamide can interact with other eye medications, especially those that also lower intra-ocular pressure. Alcohol does not typically affect its action, but excessive consumption may increase the risk of eye irritation. Certain systemic drugs, such as oral carbonic anhydrase inhibitors, may amplify the pressure-lowering effect. For a full list of potential interactions, refer to the specific product’s information sheet.
Store dorzolamide eye drops at room temperature, away from direct sunlight and moisture. Keep the bottle tightly sealed when not in use to maintain sterility. Treatment duration varies; some patients use the drops for short-term pressure control, while others require long-term therapy. Always follow the instructions printed on the product label, as formulations and dosage regimens differ between brands and strengths. For detailed usage, dosing, and administration, refer to your specific medication’s information.
This article offers general educational information about dorzolamide as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing dorzolamide may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.
